Somaxon Pharmaceuticals

Somaxon is a specialty pharmaceutical company focused on the in-licensing and development of proprietary product candidates for the treatment of diseases and disorders in the fields of psychiatry and neurology.To date, we have in-licensed three products. Our lead product, SILENOR™ (doxepin HCl), is in Phase III clinical trials for the treatment of insomnia. Our product nalmefene HCl is in a Phase II/III clinical trial for the treatment of pathological gambling and a Phase II clinical trial for smoking cessation. We are also developing a new formulation of acamprosate Ca for the treatment of certain movement disorders.
We intend to continue to build a portfolio of product candidates that target psychiatric and neurological diseases and disorders, focusing on products that are currently commercialized outside the United States, approved in the United States but with significant commercial potential for proprietary new uses, new dosages or alternative delivery systems, or in late stages of clinical development .
Somaxon is a leading specialty pharmaceutical company focused on the in-licensing and development of proprietary product candidates in the fields of psychiatry and neurology.We intend to continue to build a portfolio of product candidates that target psychiatric and neurological diseases and disorders, focusing on products that are currently commercialized outside the United States, approved in the United States but with significant commercial potential for proprietary new uses, new dosages or alternative delivery systems, or in late stages of clinical development.

Contact Details: 3721 Valley Centre Drive Suite 500 San Diego California 92130 United States of America Tel: 858.480.0400 Fax: 858.509.1761 Email: info@somaxon.com WWW: www.somaxon.com/

Loading...

Recent Publications by Somaxon Pharmaceuticals:
The sleep of African Americans: a comparative review. Researchers have not thoroughly assessed the sleep of African Americans...	29th September, 2006	Somaxon Pharmaceuticals, Inc., San Diego, CA 92130, USA.	Behav Sleep Med. 2006;4(1):29-44. DOI Direct Link

BioNews Results for Somaxon Pharmaceuticals:
Somaxon Pharmaceuticals to Present at the Thomas Weisel 2008 Healthcare Conference and NewsMakers in the Biote	SmartBrief:  Aug 29 2008 12:16PM Matching: somaxon pharmaceuticals
Somaxon Pharmaceuticals to Present at the Thomas Weisel 2008 Healthcare Conference and NewsMakers in the Biote	FinanzNachrichten.de:  Aug 29 2008 12:45AM Matching: somaxon pharmaceuticals
Somaxon Pharmaceuticals to Present at the Thomas Weisel 2008	Business Wire via MSN Money:  Aug 29 2008 12:17AM Matching: somaxon pharmaceuticals
Somaxon Pharmaceuticals to Present at the Thomas Weisel 2008 Healthcare Conference and NewsMakers in the Biote	Stockwatch:  Aug 29 2008 12:12AM Matching: somaxon pharmaceuticals
Somaxon Pharmaceuticals to Present at the Thomas Weisel 2008 Healthcare Conference and NewsMakers in the Biote	Business Wire via Yahoo!:  Aug 29 2008 12:14AM Matching: somaxon pharmaceuticals
Promote your company here: BioNewsCast - Press Release Distribution	→View more Somaxon Pharmaceuticals news.

Somaxon Pharmaceuticals (SOMX) Financial information Links from Barchart
SOMX Quote from from Barchart.com
SOMX Chart from from Barchart.com
SOMX Profile from from Barchart.com
SOMX Opinion from from Barchart.com
→View more Somaxon Pharmaceuticals finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 183 times since April 2007, the link to the organisation's website has been followed 36 times

Recent Search Terms used to find this page: somaxon.com | somaxon | somaxon | .

Search for more companies in San Diego

Search for more companies in California

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Somaxon Pharmaceuticals